Trospium chloride controlled release capsule and preparation method thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHOUGUANG FUKANG PHARMA
- Publication Date
- 2012-11-07
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to medicines, and is a trospium chloride controlled-release capsule and a preparation method thereof. Background technique
[0002] Trospium chloride capsule is a drug for treating overactive bladder. It is a new powerful M receptor blocker with high affinity and specificity for M receptors, and its lipid Low solubility, not through the blood-brain barrier.
[0003] At present, trospium chloride short-acting dosage forms in the domestic and foreign markets are generally trospium chloride tablets 20 mg (such as trade name Sanctura, Germany) and capsules. Because the drug is a symptom-improving drug, it requires long-term concomitant medication for elderly patients. However, these short-acting tablets and capsules on the market at home and abroad are taken 3 times a day, and the number of times of taking is too many to bring loaded down with trivial details to the patient, and it is difficult for the patient to persist in long-ter...